Roche’s US subsidiary Genentech breaks ground on $700 million manufacturing facility in North Carolina
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
This project shall be implemented through incorporation of a new joint venture company in Zambia
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
Subscribe To Our Newsletter & Stay Updated